Insider Buying Highlights These 3 Undervalued Small Caps In United States — Oct 7th, 2024

Over the last 7 days, the United States market has remained flat, yet it is up 32% over the past year with earnings expected to grow by 15% per annum in the coming years. In such a dynamic environment, identifying stocks that are potentially undervalued with insider buying can be an intrig...

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 4th, 2024

NewAmsterdam Pharma N.V. NAARDEN, the Netherlands and MIAMI, Oct. 04, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at...

Three Undervalued Small Caps In United States With Insider Buying To Consider — Oct 8th, 2024

The United States market has seen a significant rise of 30% over the past year, although it remained flat in the last week, with earnings expected to grow by 15% annually. In this context, identifying stocks that are perceived as undervalued and have insider buying can be an intriguing str...

NewAmsterdam Dives — And Sacrifices A Cup Base — Despite A Winning Cholesterol Study — Nov 20th, 2024

NewAmsterdam Pharma crashed Wednesday after the company said its experimental cholesterol treatment lowered "bad" LDL by roughly 50% Continue reading View comments...

3 Undervalued Small Caps In United States With Insider Buying — Oct 1st, 2024

The market has been flat over the last week but is up 33% over the past year, with earnings expected to grow by 15% per annum over the next few years. In this context, identifying undervalued small-cap stocks with insider buying can be a strategic move for investors looking to capitalize o...

Three Undervalued Small Caps In United States With Insider Buying To Consider — Oct 8th, 2024

The United States market has seen a significant rise of 30% over the past year, although it remained flat in the last week, with earnings expected to grow by 15% annually. In this context, identifying stocks that are perceived as undervalued and have insider buying can be an intriguing str...

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 4th, 2024

NewAmsterdam Pharma N.V. NAARDEN, the Netherlands and MIAMI, Oct. 04, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at...

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 4th, 2024

NewAmsterdam Pharma N.V. NAARDEN, the Netherlands and MIAMI, Oct. 04, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at...

3 Undervalued Small Caps In United States With Insider Buying — Oct 1st, 2024

The market has been flat over the last week but is up 33% over the past year, with earnings expected to grow by 15% per annum over the next few years. In this context, identifying undervalued small-cap stocks with insider buying can be a strategic move for investors looking to capitalize o...

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 4th, 2024

NewAmsterdam Pharma N.V. NAARDEN, the Netherlands and MIAMI, Oct. 04, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at...

Insider Buying Highlights These 3 Undervalued Small Caps In United States — Oct 7th, 2024

Over the last 7 days, the United States market has remained flat, yet it is up 32% over the past year with earnings expected to grow by 15% per annum in the coming years. In such a dynamic environment, identifying stocks that are potentially undervalued with insider buying can be an intrig...

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 4th, 2024

NewAmsterdam Pharma N.V. NAARDEN, the Netherlands and MIAMI, Oct. 04, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at...

3 Undervalued Small Caps In United States With Insider Buying — Oct 1st, 2024

The market has been flat over the last week but is up 33% over the past year, with earnings expected to grow by 15% per annum over the next few years. In this context, identifying undervalued small-cap stocks with insider buying can be a strategic move for investors looking to capitalize o...

NewAmsterdam Dives — And Sacrifices A Cup Base — Despite A Winning Cholesterol Study — Nov 20th, 2024

NewAmsterdam Pharma crashed Wednesday after the company said its experimental cholesterol treatment lowered "bad" LDL by roughly 50% Continue reading View comments...

3 Undervalued Small Caps In United States With Insider Buying — Oct 1st, 2024

The market has been flat over the last week but is up 33% over the past year, with earnings expected to grow by 15% per annum over the next few years. In this context, identifying undervalued small-cap stocks with insider buying can be a strategic move for investors looking to capitalize o...

Insider Buying Highlights These 3 Undervalued Small Caps In United States — Oct 7th, 2024

Over the last 7 days, the United States market has remained flat, yet it is up 32% over the past year with earnings expected to grow by 15% per annum in the coming years. In such a dynamic environment, identifying stocks that are potentially undervalued with insider buying can be an intrig...

NewAmsterdam Dives — And Sacrifices A Cup Base — Despite A Winning Cholesterol Study — Nov 20th, 2024

NewAmsterdam Pharma crashed Wednesday after the company said its experimental cholesterol treatment lowered "bad" LDL by roughly 50% Continue reading View comments...

Three Undervalued Small Caps In United States With Insider Buying To Consider — Oct 8th, 2024

The United States market has seen a significant rise of 30% over the past year, although it remained flat in the last week, with earnings expected to grow by 15% annually. In this context, identifying stocks that are perceived as undervalued and have insider buying can be an intriguing str...

3 Undervalued Small Caps In United States With Insider Buying — Oct 1st, 2024

The market has been flat over the last week but is up 33% over the past year, with earnings expected to grow by 15% per annum over the next few years. In this context, identifying undervalued small-cap stocks with insider buying can be a strategic move for investors looking to capitalize o...

Insider Buying Highlights These 3 Undervalued Small Caps In United States — Oct 7th, 2024

Over the last 7 days, the United States market has remained flat, yet it is up 32% over the past year with earnings expected to grow by 15% per annum in the coming years. In such a dynamic environment, identifying stocks that are potentially undervalued with insider buying can be an intrig...

NewAmsterdam Dives — And Sacrifices A Cup Base — Despite A Winning Cholesterol Study — Nov 20th, 2024

NewAmsterdam Pharma crashed Wednesday after the company said its experimental cholesterol treatment lowered "bad" LDL by roughly 50% Continue reading View comments...

Insider Buying Highlights These 3 Undervalued Small Caps In United States — Oct 7th, 2024

Over the last 7 days, the United States market has remained flat, yet it is up 32% over the past year with earnings expected to grow by 15% per annum in the coming years. In such a dynamic environment, identifying stocks that are potentially undervalued with insider buying can be an intrig...

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 4th, 2024

NewAmsterdam Pharma N.V. NAARDEN, the Netherlands and MIAMI, Oct. 04, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at...

NewAmsterdam Dives — And Sacrifices A Cup Base — Despite A Winning Cholesterol Study — Nov 20th, 2024

NewAmsterdam Pharma crashed Wednesday after the company said its experimental cholesterol treatment lowered "bad" LDL by roughly 50% Continue reading View comments...

NewAmsterdam Dives — And Sacrifices A Cup Base — Despite A Winning Cholesterol Study — Nov 20th, 2024

NewAmsterdam Pharma crashed Wednesday after the company said its experimental cholesterol treatment lowered "bad" LDL by roughly 50% Continue reading View comments...

3 Undervalued Small Caps In United States With Insider Buying — Oct 1st, 2024

The market has been flat over the last week but is up 33% over the past year, with earnings expected to grow by 15% per annum over the next few years. In this context, identifying undervalued small-cap stocks with insider buying can be a strategic move for investors looking to capitalize o...

NewAmsterdam Dives — And Sacrifices A Cup Base — Despite A Winning Cholesterol Study — Nov 20th, 2024

NewAmsterdam Pharma crashed Wednesday after the company said its experimental cholesterol treatment lowered "bad" LDL by roughly 50% Continue reading View comments...

NewAmsterdam Dives — And Sacrifices A Cup Base — Despite A Winning Cholesterol Study — Nov 20th, 2024

NewAmsterdam Pharma crashed Wednesday after the company said its experimental cholesterol treatment lowered "bad" LDL by roughly 50% Continue reading View comments...

NewAmsterdam Dives — And Sacrifices A Cup Base — Despite A Winning Cholesterol Study — Nov 20th, 2024

NewAmsterdam Pharma crashed Wednesday after the company said its experimental cholesterol treatment lowered "bad" LDL by roughly 50% Continue reading View comments...

3 Undervalued Small Caps In United States With Insider Buying — Oct 1st, 2024

The market has been flat over the last week but is up 33% over the past year, with earnings expected to grow by 15% per annum over the next few years. In this context, identifying undervalued small-cap stocks with insider buying can be a strategic move for investors looking to capitalize o...

NewAmsterdam Dives — And Sacrifices A Cup Base — Despite A Winning Cholesterol Study — Nov 20th, 2024

NewAmsterdam Pharma crashed Wednesday after the company said its experimental cholesterol treatment lowered "bad" LDL by roughly 50% Continue reading View comments...

NewAmsterdam Dives — And Sacrifices A Cup Base — Despite A Winning Cholesterol Study — Nov 20th, 2024

NewAmsterdam Pharma crashed Wednesday after the company said its experimental cholesterol treatment lowered "bad" LDL by roughly 50% Continue reading View comments...

Three Undervalued Small Caps In United States With Insider Buying To Consider — Oct 8th, 2024

The United States market has seen a significant rise of 30% over the past year, although it remained flat in the last week, with earnings expected to grow by 15% annually. In this context, identifying stocks that are perceived as undervalued and have insider buying can be an intriguing str...

Insider Buying Highlights These 3 Undervalued Small Caps In United States — Oct 7th, 2024

Over the last 7 days, the United States market has remained flat, yet it is up 32% over the past year with earnings expected to grow by 15% per annum in the coming years. In such a dynamic environment, identifying stocks that are potentially undervalued with insider buying can be an intrig...

3 Undervalued Small Caps In United States With Insider Buying — Oct 1st, 2024

The market has been flat over the last week but is up 33% over the past year, with earnings expected to grow by 15% per annum over the next few years. In this context, identifying undervalued small-cap stocks with insider buying can be a strategic move for investors looking to capitalize o...

Three Undervalued Small Caps In United States With Insider Buying To Consider — Oct 8th, 2024

The United States market has seen a significant rise of 30% over the past year, although it remained flat in the last week, with earnings expected to grow by 15% annually. In this context, identifying stocks that are perceived as undervalued and have insider buying can be an intriguing str...

Three Undervalued Small Caps In United States With Insider Buying To Consider — Oct 8th, 2024

The United States market has seen a significant rise of 30% over the past year, although it remained flat in the last week, with earnings expected to grow by 15% annually. In this context, identifying stocks that are perceived as undervalued and have insider buying can be an intriguing str...

Insider Buying Highlights These 3 Undervalued Small Caps In United States — Oct 7th, 2024

Over the last 7 days, the United States market has remained flat, yet it is up 32% over the past year with earnings expected to grow by 15% per annum in the coming years. In such a dynamic environment, identifying stocks that are potentially undervalued with insider buying can be an intrig...

Three Undervalued Small Caps In United States With Insider Buying To Consider — Oct 8th, 2024

The United States market has seen a significant rise of 30% over the past year, although it remained flat in the last week, with earnings expected to grow by 15% annually. In this context, identifying stocks that are perceived as undervalued and have insider buying can be an intriguing str...

NewAmsterdam Dives — And Sacrifices A Cup Base — Despite A Winning Cholesterol Study — Nov 20th, 2024

NewAmsterdam Pharma crashed Wednesday after the company said its experimental cholesterol treatment lowered "bad" LDL by roughly 50% Continue reading View comments...

NewAmsterdam Dives — And Sacrifices A Cup Base — Despite A Winning Cholesterol Study — Nov 20th, 2024

NewAmsterdam Pharma crashed Wednesday after the company said its experimental cholesterol treatment lowered "bad" LDL by roughly 50% Continue reading View comments...

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 4th, 2024

NewAmsterdam Pharma N.V. NAARDEN, the Netherlands and MIAMI, Oct. 04, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at...

Insider Buying Highlights These 3 Undervalued Small Caps In United States — Oct 7th, 2024

Over the last 7 days, the United States market has remained flat, yet it is up 32% over the past year with earnings expected to grow by 15% per annum in the coming years. In such a dynamic environment, identifying stocks that are potentially undervalued with insider buying can be an intrig...

Insider Buying Highlights These 3 Undervalued Small Caps In United States — Oct 7th, 2024

Over the last 7 days, the United States market has remained flat, yet it is up 32% over the past year with earnings expected to grow by 15% per annum in the coming years. In such a dynamic environment, identifying stocks that are potentially undervalued with insider buying can be an intrig...

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 4th, 2024

NewAmsterdam Pharma N.V. NAARDEN, the Netherlands and MIAMI, Oct. 04, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at...

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 4th, 2024

NewAmsterdam Pharma N.V. NAARDEN, the Netherlands and MIAMI, Oct. 04, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at...

Three Undervalued Small Caps In United States With Insider Buying To Consider — Oct 8th, 2024

The United States market has seen a significant rise of 30% over the past year, although it remained flat in the last week, with earnings expected to grow by 15% annually. In this context, identifying stocks that are perceived as undervalued and have insider buying can be an intriguing str...